Schizophrenia Research
Volume 81, Issue 1 , Pages 115-117 , 1 January 2006

Clozapine as a short-term antipsychotic medication in patients with schizophrenia

Received 24 June 2005

References 

  1. Breier A, Buchanan RW, Kirkpatrick B, et al. Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia. Am. J. Psychiatry. 1994;151:20–26
  2. Farber NB, Price MT, Labruyere J, et al. Antpsychotic drugs block phencyclidine receptor-mediated neurotoxicity. Biol. Psychiatry. 1993;34:119–121
  3. Golgman L, Bennett JC, Ausiello D, et al. In: Cecil Textbook of Medicine. 22nd ed.. W.B. Saunders; 2003;p. 506–509
  4. Kane J, Honigfeld G, Singer J, et al. Clozaril Collaborative Study Group, Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch. Gen. Psychiatry. 1988;45:789–796
  5. Laruelle M. The role of endogenous sensitization in the pathophysiology of schizophrenia: implication from recent brain imaging studies. Brain Res. Rev. 2000;31:371–384
  6. Lieberman JA, Sheitman BB, Kinon BJ. Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticity. Neuropsychopharmacology. 1997;17:205–229
  7. Victor M, Ropper AH. In: Principle of Neurology. 7th ed.. New York: McGraw-Hill; 2001;p. 973–975

PII: S0920-9964(05)00394-4

doi: 10.1016/j.schres.2005.09.006

Schizophrenia Research
Volume 81, Issue 1 , Pages 115-117 , 1 January 2006

Article Tools